GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Organovo Holdings Inc (NAS:ONVO) » Definitions » E10

Organovo Holdings (Organovo Holdings) E10 : $-5.77 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Organovo Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Organovo Holdings's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.400. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-5.77 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 12 years, the highest 3-Year average E10 Growth Rate of Organovo Holdings was 14.30% per year. The lowest was 14.30% per year. And the median was 14.30% per year.

As of today (2024-04-30), Organovo Holdings's current stock price is $1.04. Organovo Holdings's E10 for the quarter that ended in Dec. 2023 was $-5.77. Organovo Holdings's Shiller PE Ratio of today is .


Organovo Holdings E10 Historical Data

The historical data trend for Organovo Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organovo Holdings E10 Chart

Organovo Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -9.90 -9.37 -7.12 -6.24

Organovo Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.72 -6.24 -6.20 -5.93 -5.77

Competitive Comparison of Organovo Holdings's E10

For the Biotechnology subindustry, Organovo Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organovo Holdings's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Organovo Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Organovo Holdings's Shiller PE Ratio falls into.



Organovo Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Organovo Holdings's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.4/129.4194*129.4194
=-0.400

Current CPI (Dec. 2023) = 129.4194.

Organovo Holdings Quarterly Data

per share eps CPI Adj_EPS
201403 -1.600 99.695 -2.077
201406 -1.600 100.560 -2.059
201409 -2.200 100.428 -2.835
201412 -1.800 99.070 -2.351
201503 -2.000 99.621 -2.598
201506 -2.000 100.684 -2.571
201509 -2.400 100.392 -3.094
201512 -2.200 99.792 -2.853
201603 -1.812 100.470 -2.334
201606 -1.800 101.688 -2.291
201609 -2.000 101.861 -2.541
201612 -1.800 101.863 -2.287
201703 -2.000 102.862 -2.516
201706 -2.000 103.349 -2.505
201709 -1.800 104.136 -2.237
201712 -1.400 104.011 -1.742
201803 -1.400 105.290 -1.721
201806 -1.400 106.317 -1.704
201809 -1.000 106.507 -1.215
201812 -1.200 105.998 -1.465
201903 -1.200 107.251 -1.448
201906 -1.000 108.070 -1.198
201909 -1.000 108.329 -1.195
201912 -0.600 108.420 -0.716
202003 -0.400 108.902 -0.475
202006 -0.400 108.767 -0.476
202009 -1.360 109.815 -1.603
202012 -0.370 109.897 -0.436
202103 -0.300 111.754 -0.347
202106 -0.290 114.631 -0.327
202109 -0.400 115.734 -0.447
202112 -0.400 117.630 -0.440
202203 -0.220 121.301 -0.235
202206 -0.370 125.017 -0.383
202209 -0.380 125.227 -0.393
202212 -0.370 125.222 -0.382
202303 -0.850 127.348 -0.864
202306 -0.460 128.729 -0.462
202309 -0.460 129.860 -0.458
202312 -0.400 129.419 -0.400

Add all the adjusted EPS together and divide 10 will get our e10.


Organovo Holdings  (NAS:ONVO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Organovo Holdings E10 Related Terms

Thank you for viewing the detailed overview of Organovo Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Organovo Holdings (Organovo Holdings) Business Description

Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Executives
David Gobel director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Vaidehi Joshi director C/O ORGANOVO HOLDINGS, INC., 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO CA 92121
Alison Tjosvold Milhous director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Adam K Stern director STERN AEGIS VENTURES, 810 7TH AVENUE 22ND FLOOR, NEW YORK NY 10019
Thomas Hess officer: President, CFO and PFO 366 MADISON AVE. 12TH FLOOR, NEW YORK NY 10017
Douglas Jay Cohen director 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Thomas E Jurgensen officer: General Counsel & Secretary 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Jeffrey N. Miner officer: Chief Scientific Officer 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075
Chris Heberlig officer: President and CFO C/O KINIKSA PHARMACEUTICALS, LTD., CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON D0 HM11
Keith Murphy director, officer: Executive Chairman 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Steven George Hughes officer: Chief Medical Officer 6275 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Carolyn Beaver director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
David Shapiro director C/O INTERCEPT PHARMACEUTICALS, INC., 18 DESBROSSES ST., NEW YORK NY 10013
Presnell Sharon Collins officer: EVP, Research & Development 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Taylor Crouch director, officer: CEO & President 440 STEVENS AVENUE, SUITE 200, SOLANA BEACH CA 92075